Another NOAC.
medscape.com/viewarticle/84...
Known as Savaysa in North America, the novel oral anticoagulant (NOAC), which can be given once daily, was approved for essentially the same indications by the US Food and Drug Administration in January 2015.
Vaccine with AF and Edoxaban
Edoxaban & high Glucose levels
NOACs Perform Worse Than Warfarin in Real-World Study.
Dabigatran or Apixaban?
